STUDY LOCATION
|
ENTRY YEARS
|
NUMBER OF PARTICIPANTS (MILLIONS)
|
STORED BLOOD
|
AMERICAS
|
|
|
|
| American Cancer Society Cancer Prevention Study I |
1959 - 1960 |
1.0 (M&F) |
No |
| American Cancer Society Cancer Prevention Study II |
1982 - 1983 |
1.2 (M&F) |
Yes |
| American Cancer Society Cancer Prevention Study III |
2006 - 2013 |
0.3 (M & F) |
Yes |
| AllofUs (US Precision Medicine Initiative) |
2018 - |
0.22* (M&F) |
Yes |
| California Teachers Study (CTS) |
1995 - 1996 |
0.13 (F) |
Yes |
| Cooper Center Longitudinal Study |
1970 - |
0.11* (M&F) |
Yes |
| Connect For Cancer Prevention Study (Connect) |
2021 - 2027 |
0.2* (M&F) |
Yes |
| Cuba Prospective Study |
1996 - 2002 |
0.15 (M&F) |
No |
| Health Professionals' Follow Up Study (HPFS) |
1986 |
0.05 (M) |
Yes |
| Kaiser Permanente Research Program on Genes, Environment, and Health (RPGEH) |
2008 - |
0.21* (M&F) |
Yes |
| Mexico City Prospective Study |
1998 - 2004 |
0.15 (M&F) |
Yes |
| Million Veteran Program |
2011 - |
0.75* (M&F) |
Yes |
| Multi-ethnic Cohort Study |
1993 -1997 |
0.2 (M&F) |
Yes |
| National Health Interview Survey |
1997-2004 |
0.2 (M&F) |
No |
| Newfoundland and Labrador Genome Project |
2018 - |
0.52* (M&F) |
Yes |
| NIH-AARP Diet and Health Study |
1995 -1996 |
0.57 (M&F) |
No |
| Nurses' Health Study I |
1976 - 1976 |
0.12 (F) |
Yes |
| Nurses' Health Study 2 |
1989 - 1989 |
0.12 (F) |
Yes |
| Nurses' Health Study 3 |
2010 - |
(M&F) |
Yes |
| Ontario Health Study (OHS) |
2010 -2017 |
0.23 (M&F) |
Yes |
| Physicians' Health Study I & II (PHS) |
1982 - 2011 |
0.04 (M) |
Yes |
| Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO) |
1993 - 2001 |
0.15 (M&F) |
Yes |
| Women's Health Initiative (WHI) |
1993 -1998 |
0.09 (F) |
Yes |
| Women's Health Study |
1992 - 1995 |
0.04 (F) |
Yes |
ASIA
|
|
|
|
| BangladEsh Longitudinal Investigation of Emerging Vascular Events study (BELIEVE) |
2016 - 2020 |
0.08 (M&F) |
Yes |
| Chennai Prospective Study |
1998 - 2001 |
0.5 (M&F) |
No |
| China Kadoorie Biobank |
2004 - 2008 |
0.5 (M&F) |
Yes |
| Elderly Health Service, Hong Kong |
1998 - 2001 |
0.13 (M&F) |
No |
|
Indian Study of Healthy Ageing (ISHA)
|
|
0.2* |
Yes |
| Japan Public Health Center-based Prospective Study (JPHC Study) |
1990 - 1993 |
0.14 (M&F) |
Yes |
| Japan Public Health Center-based Prospective Study for the Next generation (JPHC-NEXT) |
2011 - 2016 |
0.12 (M&F) |
Yes |
| Kailuan study |
2006 - 2007 |
0.1 (M&F) |
Yes |
| Kangbuk Samsung Health Study |
2002 - |
0.28* (M&F) |
Yes |
Korean Cancer Prevention Study I
|
1992 - 1995 |
1.32 (M&F) |
No |
| Korean Cancer Prevention Study II |
2004 - 2011 |
0.15 (M&F)
|
Yes |
| Korean Genome and EpidemiologyStudy (KoGES) |
2001 - 2013 |
0.25 (M&F) |
Yes |
| Longitudinal Health Insurance Database 2000 |
1996 - 2000 |
0.20 (M&F) |
No |
| Malaysian Cohort |
2007-2013 |
0.11 (M&F) |
Yes |
| Mumbai Studies |
1991 - 1997 |
0.15 (M&F) |
No |
| PERSIAN Cohort Study |
2014 - |
0.18* (M&F) |
Yes |
Qatar Genome Programme (& Biobank)
|
2015 - |
|
Yes |
| Russian Prospective Study |
1999 - 2008 |
0.21 (M&F) |
Yes |
Saudi Human Genome Program (SHGP)
|
2013 - |
0.1* (M&F) |
Yes |
| Shanghai Men's Health Study |
2002 - 2006 |
0.06 (M) |
Yes |
| Shanghai Womens' Health Study |
1997 - 2000 |
0.07 (F) |
Yes |
| Taiwan Biobank |
2012 - |
0.1* (M&F) |
Yes |
| Taiwan MJ Cohort Study |
1994 |
0.59 (M&F) |
Yes |
Taizhou Biobank /Taizhou Longitudinal Cohort Study
|
2007- |
0.2* (M&F) |
Yes |
| Tohoku Medical Megabank Project |
2013 - 2016 |
0.14 (M&F) |
Yes |
| Trivandrum Urban/Rural Tobacco Study |
2002 - 2006 |
0.4 (M) |
Some |
AUSTRALAsia
|
|
|
|
| 45 and Up |
2006 - 2009 |
0.26 (M&F) |
Yes |
EUROPE
|
|
|
|
| Apolipoprotein-related Mortality RISk (AMORIS) |
1985 - 1996 |
0.81 (M&F) |
Yes |
| Constances |
2012 - 2019 |
0.21 (M&F) |
Yes |
| EPIC (European Prospective Investigation into Cancer and Nutrition) |
1992 - 1999 |
0.52 (M&F) |
Yes |
| Generations Study (Breakthrough Generations) |
2003 - 2015 |
0.11 (F) |
Yes |
| German National Cohort (NAKO) |
2014- |
0.1* (M&F) |
Yes |
| JANUS Serum Bank |
1973 - 2004 |
0.32 (M&F) |
Yes |
| Lifelines Cohort Study & Biobank |
2006 - 2013 |
0.17 (M&F) |
Yes |
| Million Women Study |
1996 - 2001 |
1.32 (F) |
Yes |
| Netherlands Cohort Study |
1986 - 1986 |
0.12 (M&F) |
No |
| Nord-Trondelag Health Study (HUNT) |
1984 - 2019 |
0.17 (M&F) |
Yes |
| Norwegian Family Based Life Course Study |
1960 - 2011 |
5.2 (M&F) |
Yes |
| Norwegian Women and Cancer study |
1991 - 2006 |
0.17 (F) |
Yes |
| Stockholm Public Health Cohort (SPHC) |
2002 - 2010 |
0.1 (M&F) |
No |
| UK Biobank |
2006 - 2010 |
0.5 (M&F) |
Yes |
| UK Blood Donor Cohorts (INTERVAL & COMPARE) |
2012 - |
0.1* (M&F) |
Yes |
| UKCTOCS (UK Collaborative Trial of Ovarian Cancer Screening) Longitudinal Women’s Cohort (UKLWC) |
2001 - 2005 |
0.2 (F) |
Yes |
| Vorarlberg Health Monitoring and Promotion Programme |
1985 - 2005 |
0.19 (M&F) |
Yes |
INTERNATIONAL
|
|
|
|
| PURE (Prospective Urban Rural Epidemiological Study) |
2003 - 2009 |
0.4 (M&F) |
Yes |
collABORATIONS OF PROSPECTIVE STUDIES
|
|
|
|
| Asia Cohort Consortium (ACC) |
Various |
1.1 (M&F) |
|
| Asia-Pacific Cohort Studies Collaboration |
1981 - 1992 |
0.6 (M&F) |
Yes |
| BBMRI-NL Biobank |
Various |
0.4 (M&F) |
Yes |
| Canadian Partnership for Tomorrow's Health (CanPath) |
2009 - 2016 |
0.33 (M&F) |
Yes |
| Cohort of Norway (CONOR) |
1994 - 2003 |
0.19 (M&F) |
No |
| Emerging Risk Factors Collaboration |
Various |
2.3 (M&F) |
No |
| Global BMI Mortality Collaboration |
Various |
10.6 (M&F) |
No |
| Japanese Prospective Studies |
Various |
0.4 (M&F) |
No |
| LIFEPATH (Life-course biological pathways underlying social differences in healthy aging) |
|
0.24 (M&F) |
Yes |
| Northern Sweden Health and Disease Study |
1985 - |
0.14 (M&F) |
Yes |
| Prospective Studies Collaboration |
Various |
1.2 (M&F) |
No |
| Taiwan Prospective Studies |
1999 - 2009 |
0.5 (M&F) |
Yes |
| US National Cancer Institute BMI Pooling Project |
Various |
1.46 (M&F) |
No |
| US National Cancer Institute Cohort Consortium |
Various |
9.00 |
Yes |
retrospective and other
|
|
|
|
| Hong Kong Retrospective Study |
1997 - 1999 |
0.04 (M&F) |
No |
| Million Death Study |
2002 - 2004 |
14.0* (M&F) |
No |
| Indirect Smoking Mortality Estimates |
1950 - |
(M&F) |
No |
| INTERHEART retrospective |
1999 - 2003 |
0.03 (M&F) |
Yes |
| INTERSTROKE retrospective |
2007 - 2014 |
0.03 (M&F) |
Yes |
| NCD Risk Factor Collaboration (NCD-RisC) |
1950 - |
20 (M&F) |
No |
| South Africa Retrospective |
1999 - |
0.48 (M&F) |
No |
